It would be of great interest to determine if RECQ4 clinical mutations induce deregulation of the RECQ4-APC/C interaction, leading to abnormal replication origin firing and high DNA content, which contributes to developmental abnormalities associated with RTS and cancer pathogenesis. This evidence concerns the gene RECQL4 and cancer.